Peter Dirks

Researcher
  • The Hospital for Sick Children
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Multiple Cancers

    The Terry Fox New Frontiers Program Project Grant in Injury and stress driven lineage plasticity underlying cancer stemness

    Cancer isn’t a single disease, nor are tumours made up of just one type of cell. Cancers are complex communities of diverse cells that can change over time, allowing them to adapt to new conditi...

    Read More
  • Brain Cancer

    Immune interception for malignant gliomas in children, adolescents and young adults

    Cancer is often talked about as one disease, but it’s actually hundreds of diseases, each with unique mutations, behaviours and responses to treatment. This is especially true for high-grade gli...

    Read More
  • Multiple Cancers

    Determinants of stemness that underlie high risk or relapse disease

    There’s an analogy that Dr. John Dick likes to use to describe cancer. For him, cancer is like a weed, with the tumour being the leafy part that sits above ground. The roots, on the other hand, ...

    Read More
  • Completed
    Multiple Cancers

    Development of stemness-based prognostic biomarkers and therapeutic targets

    There is an analogy senior scientist Dr. John Dick uses when explaining his TFRI-funded cancer stem cell (CSC) research. He compares cancer to a weed that has a separate root to the stem, branches and...

    Read More

Related News & Events

  • TFRI News|August 04, 2026

    Five leading cancer research teams receive $33M to drive transformative discoveries

    Five Canadian cancer research teams have launched bold and innovative projects supported by $33 million in funding through the Terry Fox New Frontiers...

  • TFRI News|February 11, 2026

    Discovery of unique brain tumour subtypes offers hope for targeted glioma therapies

    Terry Fox-funded researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas.

  • Research Highlight|September 01, 2020

    Developing precision medicine alternatives for triple negative breast cancer

    TFRI-funded scientists in Toronto have made a discovery that could unlock precision medicine treatments for patients diagnosed with triple negative br...

  • All News & Events